Numerous delivery strategies, e.g., nanocarriers, MOFs, and stimuli-responsive systems, have been developed to mitigate these issues, but they often suffer from inherent limitations such as uncontrolled release, insufficient targeting, and unresolved long-term toxicity, which can still lead to potential cytotoxicity and systemic biosafety concerns [19]
Studies show that semaglutide may help protect the kidneys, especially in patients with renal impairment and those at risk for heart failure
Some peptides, particularly BPC-157 and Larazotide, have shown promise for the inflammation and barrier-function pathways that often drive IBS symptoms
For some individuals, the side effects of GLP-1s tend to improve over time
NAC: The Builder NAC is primarily used to provide the raw materials for internal production